시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
바이오리액터 시장 보고서(2025년)
Bioreactors Global Market Report 2025
상품코드 : 1716924
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 175 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,661,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,629,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 12,596,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

바이오리액터 시장 규모는 향후 수년간 급성장할 것으로 예측됩니다. 예측 기간의 성장은 구조에 대한 규제 지원의 강화, 첨단 요법의 사용 증가 등의 요인에 의한 것으로 예측됩니다.

바이오의약품에 대한 수요 증가가 향후 몇 년간의 바이오리액터 시장의 성장을 견인할 것으로 예측됩니다. 연구의 진보, 맞춤형 의료의 대두, 혁신적인 치료의 필요성 등에 힘쓰고 있으며, 세계의 헬스케어 성과의 향상에 공헌하고 있습니다. 일정한 품질을 확보하고 제조 비용을 낮추고 생명을 바꾸는 혁신적인 의약품의 개발을 지원합니다. 예를 들어, 2024년 5월, 미국에 본사를 둔 무역 협회인 미국 제약 연구 및 제조업체의 데이터에 따르면 미국 바이오 제약 산업은 2022년에 직접 생산에서 8,000억 달러, 공급업체 및 관련 부문에서 8,000억 달러를 포함하여 총 1조 6,500억 달러 이상의 생산액을 창출했으며 이는 미국 경제의 3.6%를 차지하는 규모입니다.

바이오리액터 시장 주요 기업은 보다 복잡한 생물학적 배양의 성장에 대응하기 위해 고정층 바이오리액터 등의 혁신적인 솔루션의 창출에 주력하고 있습니다. 예를 들어, 2024년 10월 벨기에에 본사를 둔 생명공학 회사인 유니버셀스 테크놀로지스는 Scale-X 넥소 바이오리액터를 출시했습니다. Scale-X Nexo는 대형 모델로 원활하게 확장할 수 있고, 배지와 시약 사용량을 줄이며, 기존 보급형 바이오리액터에 비해 운영 비용을 최대 60%까지 절감할 수 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나 바이러스 감염의 영향과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 전략

제36장 부록

KTH
영문 목차

영문목차

A bioreactor is a specialized system designed to maintain optimal conditions for biological processes, supporting the growth and function of cells, microorganisms, or enzymes. It ensures suitable environmental factors, including temperature, pH, oxygen, and nutrient supply, to enable desired biochemical reactions. Bioreactors are commonly utilized in industries such as pharmaceuticals, food production, and wastewater treatment.

The primary types of bioprocesses used in bioreactors are batch, fed-batch, and continuous. Bioreactors can support both batch and fed-batch processes, offering flexibility in optimizing production based on the complexity of the product and required yields. They are used with various cell types, including mammalian, bacterial, and yeast cells, and incorporate different control methods, such as manual and automated systems. Bioreactors are employed in applications ranging from lab-scale and pilot-scale production to full-scale production, serving end users such as research and development (R&D) organizations, biopharmaceutical manufacturers, and contract manufacturing organizations (CMOs).

The bioreactors market research report is one of a series of new reports from The Business Research Company that provides bioreactors market statistics, including the bioreactors industry global market size, regional shares, competitors with the bioreactors market share, detailed bioreactors market segments, market trends, and opportunities, and any further data you may need to thrive in the bioreactors industry. These bioreactors market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The bioreactors market size has grown rapidly in recent years. It will grow from $9.22 billion in 2024 to $10.64 billion in 2025 at a compound annual growth rate (CAGR) of 15.2%. The growth observed during the historic period can be attributed to several factors, including the increasing demand for biopharmaceuticals, the rise in cell and gene therapy research, a growing focus on personalized medicine, the adoption of single-use bioreactor technology, and the need for more efficient manufacturing processes.

The bioreactors market size is expected to see rapid growth in the next few years. It will grow to $18.58 billion in 2029 at a compound annual growth rate (CAGR) of 14.9%. The growth anticipated during the forecast period can be attributed to factors such as increased investment in biotechnology research, the rising prevalence of chronic diseases, growing demand for vaccines and therapeutic proteins, enhanced regulatory support for biomanufacturing, and the increasing use of advanced therapies. Key trends for this period include advancements in biotechnology, improvements in automation and control systems, growth in bioprocess development, enhancements in manufacturing efficiency, and a rising need for scalable production solutions.

The rising demand for biopharmaceuticals is anticipated to drive the growth of the bioreactors market in the coming years. Biopharmaceuticals are therapeutic products derived from biological sources, including proteins, cells, and living organisms, used to prevent, treat, or manage various diseases. This growing demand is fueled by advancements in medical research, the rise of personalized medicine, and the need for innovative treatments, which contribute to improved healthcare outcomes globally. Bioreactors play a crucial role in the biopharmaceutical sector by enabling the efficient and scalable production of therapeutic products. They ensure consistent quality, lower production costs, and support the development of innovative, life-changing medicines. For example, in May 2024, data from Pharmaceutical Research and Manufacturers of America, a U.S.-based trade association, revealed that the U.S. biopharmaceutical industry generated over $1.65 trillion in total output in 2022, including $800 billion from direct production and another $800 billion from suppliers and related sectors, representing 3.6% of the U.S. economy. Consequently, the increasing demand for biopharmaceuticals is fueling the growth of the bioreactors market.

Leading companies in the bioreactors market are focusing on creating innovative solutions, such as fixed-bed bioreactors, to accommodate the growth of more complex biological cultures. Fixed-bed bioreactors utilize a solid support structure, often made from porous materials such as beads, fibers, or granules, to which biological organisms adhere. This design improves mass transfer, reduces shear stress, and offers better control over biological processes. For example, in October 2024, Univercells Technologies, a biotechnology company based in Belgium, introduced the Scale-X Nexo bioreactor. This advanced bioreactor, with a 0.5 m2 growth surface, is tailored to optimize cell culture process development, delivering significant advantages for biopharmaceutical companies and research organizations. The Scale-X Nexo enables seamless scalability to larger models, reduces media and reagent usage, and can cut operational costs by up to 60% compared to conventional entry-level bioreactors. Furthermore, it integrates with Skaia Vision application software, enhancing productivity by providing accurate cell count estimates without requiring direct sampling.

In December 2022, MilliporeSigma, a U.S.-based life sciences organization, acquired Erbi Biosystems Inc. for an undisclosed sum. This acquisition aims to enhance MilliporeSigma's upstream portfolio for therapeutic proteins by incorporating Erbi Biosystems' advanced 2 ml micro-bioreactor technology. The integration supports scalable, automated perfusion cell culture processes and accelerates the creation of life-enhancing therapeutics. Erbi Biosystems Inc., a U.S.-based biotechnology firm, specializes in the development of micro-bioreactor systems for optimizing cell culture and bioprocesses.

Major players in the bioreactors market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, GE HealthCare Technologies Inc., Cytiva Bioscience Holding Ltd., Sartorius AG, Cellexus Ltd., Getinge AB, Eppendorf AG, ZETA Holding, Pierre Guerin, Broadley-James Corporation, PBS Biotech Inc., TAP Biosystems, Solida Biotech GmBH, BBI-Biotech GmbH, HiTec Zang GmbH, Xiamen Ollital Technology Co. Ltd., Bioengineering AG, Infors AG, Univercells Technologies SA, CerCell A/S, Bailun Biotechnology Co. Ltd., BioNet, and Shanghai Ritai Medicine Equipment Project Co. Ltd.

North America was the largest region in the bioreactors market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in bioreactors report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the bioreactors market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The bioreactors market consists of sales of stirred-tank bioreactors (STRs), airlift bioreactors, bubble column bioreactors, and packed-bed bioreactors. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Bioreactors Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on bioreactors market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for bioreactors ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The bioreactors market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Bioreactors Market Characteristics

3. Bioreactors Market Trends And Strategies

4. Bioreactors Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Bioreactors Growth Analysis And Strategic Analysis Framework

6. Bioreactors Market Segmentation

7. Bioreactors Market Regional And Country Analysis

8. Asia-Pacific Bioreactors Market

9. China Bioreactors Market

10. India Bioreactors Market

11. Japan Bioreactors Market

12. Australia Bioreactors Market

13. Indonesia Bioreactors Market

14. South Korea Bioreactors Market

15. Western Europe Bioreactors Market

16. UK Bioreactors Market

17. Germany Bioreactors Market

18. France Bioreactors Market

19. Italy Bioreactors Market

20. Spain Bioreactors Market

21. Eastern Europe Bioreactors Market

22. Russia Bioreactors Market

23. North America Bioreactors Market

24. USA Bioreactors Market

25. Canada Bioreactors Market

26. South America Bioreactors Market

27. Brazil Bioreactors Market

28. Middle East Bioreactors Market

29. Africa Bioreactors Market

30. Bioreactors Market Competitive Landscape And Company Profiles

31. Bioreactors Market Other Major And Innovative Companies

32. Global Bioreactors Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Bioreactors Market

34. Recent Developments In The Bioreactors Market

35. Bioreactors Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기